Status:
COMPLETED
ROSCAP: Reduction of Smoking in Cardiac Patients Study
Lead Sponsor:
National Institutes of Health (NIH)
Conditions:
Nicotine Dependence
Tobacco Dependence
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Background. The ROSCAP Study was a randomized controlled trial in heart disease patients to test the effect of a smoking reduction intervention on cigarettes per day (cpd) and biochemical and clinical...
Eligibility Criteria
Inclusion
- smoked at least 15 cigarettes per day and had one of 11 cardiovascular disorders: history of myocardial infarction, coronary artery bypass surgery, angioplasty, stent placement, thrombolytic therapy, angina, arrhythmia, a history of cardiac arrest, greater than 50% coronary artery stenosis by angiography, ischemia on exercise tolerance testing or congestive heart failure, required to confirm that they were unwilling or uninterested in setting a stop smoking date in the next 30 days.
Exclusion
- 1\) unstable angina within the past 2 weeks, 2) unstable psychiatric or substance use disorders or 3) contraindications to nicotine replacement therapy (including pregnancy or intention to become pregnant)
Key Trial Info
Start Date :
October 1 2000
Trial Type :
INTERVENTIONAL
End Date :
January 1 2005
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT00301626
Start Date
October 1 2000
End Date
January 1 2005
Last Update
October 24 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Minneapolis VAMC (111-0)
Minneapolis, Minnesota, United States, 55417